# Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea

> **NCT00255229** · PHASE2 · COMPLETED · sponsor: **AHS Cancer Control Alberta** · enrollment: 130 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** Glutamine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00255229
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2016-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00255229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00255229, "Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00255229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*